SQNM Still Has Potential for a Double
One of my recent favorites, Sequenom Inc (NasdaqGM:SQNM) has seen shares surge from the $5 range back in April to a recent high of $23. Unfortunately, they can’t cure Down syndrome. Fortunately, the company has developed what many experts anticipate being the industry standards test for If we see a dip back into support at around 18, near-term, my guess is that many investors will be adding at that point in hopes of a run into the $30-$40 range, which is not out of the question if the test does live up to its hype. With shares selling off into the $20 range today, now is a great time to roll your sleeves up and conduct a little due dilly of your own on SQNM.
Labels: Sequenom Inc, SQNM
posted by "Staff" at
10:18 AM
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home